Zobrazeno 1 - 10
of 50
pro vyhledávání: '"Garry Ceccon"'
Autor:
Garry Ceccon, Michael Wollring, Anna Brunn, Martina Deckert, Dirk Waldschmidt, Gereon R. Fink, Norbert Galldiks
Publikováno v:
Case Reports in Oncology, Vol 13, Iss 1, Pp 35-42 (2020)
Leptomeningeal carcinomatosis is an extremely rare, but devastating complication in pancreatic cancer patients with a poor prognosis despite multimodal treatment. We present a 51-year-old male patient with the very rare condition of leptomeningeal ca
Externí odkaz:
https://doaj.org/article/e8c63d5d898f4aa4bfe0d0670a112c59
Autor:
Alexander Heinzel, Daniela Dedic, Norbert Galldiks, Philipp Lohmann, Gabriele Stoffels, Christian P. Filss, Martin Kocher, Filippo Migliorini, Kim N. H. Dillen, Stefanie Geisler, Carina Stegmayr, Antje Willuweit, Michael Sabel, Marion Rapp, Michael J. Eble, Marc Piroth, Hans Clusmann, Daniel Delev, Elena K. Bauer, Garry Ceccon, Veronika Dunkl, Jurij Rosen, Caroline Tscherpel, Jan-Michael Werner, Maximilian I. Ruge, Roland Goldbrunner, Jürgen Hampl, Carolin Weiss Lucas, Ulrich Herrlinger, Gabriele D. Maurer, Joachim P. Steinbach, Jörg Mauler, Wieland A. Worthoff, Bernd N. Neumaier, Christoph Lerche, Gereon R. Fink, Nadim Jon Shah, Felix M. Mottaghy, Karl-Josef Langen
Publikováno v:
Cancers, Vol 14, Iss 14, p 3336 (2022)
O-(2-[18F]fluoroethyl)-L-tyrosine (FET) is a widely used amino acid tracer for positron emission tomography (PET) imaging of brain tumours. This retrospective study and survey aimed to analyse our extensive database regarding the development of FET P
Externí odkaz:
https://doaj.org/article/47bf46ed8c144cdf8805fc9b22dc4798
Autor:
Philipp Lohmann, Martin Kocher, Garry Ceccon, Elena K. Bauer, Gabriele Stoffels, Shivakumar Viswanathan, Maximilian I. Ruge, Bernd Neumaier, Nadim J. Shah, Gereon R. Fink, Karl-Josef Langen, Norbert Galldiks
Publikováno v:
NeuroImage: Clinical, Vol 20, Iss , Pp 537-542 (2018)
Background: The aim of this study was to investigate the potential of combined textural feature analysis of contrast-enhanced MRI (CE-MRI) and static O-(2-[18F]fluoroethyl)-L-tyrosine (FET) PET for the differentiation between local recurrent brain me
Externí odkaz:
https://doaj.org/article/6f19c23d87994d338ea7d72a39e378e1
Autor:
Philipp Lohmann, Mai A. Elahmadawy, Robin Gutsche, Jan-Michael Werner, Elena K. Bauer, Garry Ceccon, Martin Kocher, Christoph W. Lerche, Marion Rapp, Gereon R. Fink, Nadim J. Shah, Karl-Josef Langen, Norbert Galldiks
Publikováno v:
Cancers, Vol 12, Iss 12, p 3835 (2020)
Currently, a reliable diagnostic test for differentiating pseudoprogression from early tumor progression is lacking. We explored the potential of O-(2-[18F]fluoroethyl)-L-tyrosine (FET) positron emission tomography (PET) radiomics for this clinically
Externí odkaz:
https://doaj.org/article/a629cd7300fc4d33bb74fa913a6a153c
Autor:
Garry Ceccon, Jan-Michael Werner, Veronika Dunkl, Caroline Tscherpel, Gabriele Stoffels, Anna Brunn, Martina Deckert, Gereon R. Fink, Norbert Galldiks
Publikováno v:
International Journal of Molecular Sciences, Vol 19, Iss 4, p 1090 (2018)
Novel therapeutic targets in malignant glioma patients are urgently needed. Point mutations of the v-Raf murine sarcoma viral oncogene homolog B (BRAF) gene occur predominantly in melanoma patients, but may also occur in gliomas. Thus, this is a targ
Externí odkaz:
https://doaj.org/article/160d71c50cb942efb1cfc920d9faca1f
Autor:
Norbert Galldiks, Ulrich Herrlinger, Karl-Josef Langen, Gereon R. Fink, Gerrit H. Gielen, Christoph Kabbasch, Simone Marnitz, Eren Celik, Christian Baues, Gabriele Stoffels, Niklas Schäfer, Elena K. Bauer, Philipp Lohmann, Caroline Tscherpel, Christina Schaub, Garry Ceccon, Johannes Weller, Jan-Michael Werner
Purpose:The CeTeG/NOA-09 phase III trial demonstrated a significant survival benefit of lomustine–temozolomide chemoradiation in patients with newly diagnosed glioblastoma with methylated O6-methylguanine-DNA methyltransferase (MGMT) promoter. Foll
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd015f2ec7209eacf3a9d6eed62bc87a
https://doi.org/10.1158/1078-0432.c.6530673
https://doi.org/10.1158/1078-0432.c.6530673
Autor:
Norbert Galldiks, Ulrich Herrlinger, Karl-Josef Langen, Gereon R. Fink, Gerrit H. Gielen, Christoph Kabbasch, Simone Marnitz, Eren Celik, Christian Baues, Gabriele Stoffels, Niklas Schäfer, Elena K. Bauer, Philipp Lohmann, Caroline Tscherpel, Christina Schaub, Garry Ceccon, Johannes Weller, Jan-Michael Werner
Supplemental Figure 1 shows increase of time-to-peak supporting the diagnosis of pseudoprogression
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c8b4a87c5d272459da87cba4ac26d76
https://doi.org/10.1158/1078-0432.22481367.v1
https://doi.org/10.1158/1078-0432.22481367.v1
Autor:
Garry Ceccon, Philipp Lohmann, Erkan Celik, Christian Baues, Norbert Galldiks, Caroline Tscherpel, E K Bauer, Gereon R. Fink, Christoph Kabbasch, Gabriele Stoffels, Gerrit H. Gielen, Christina Schaub, Jan-Michael Werner, Johannes Weller, Ulrich Herrlinger, Karl-Josef Langen, Simone Marnitz, Niklas Schäfer
Publikováno v:
Clinical cancer research 27(13), 3704-3713 (2021). doi:10.1158/1078-0432.CCR-21-0471
Purpose: The CeTeG/NOA-09 phase III trial demonstrated a significant survival benefit of lomustine–temozolomide chemoradiation in patients with newly diagnosed glioblastoma with methylated O6-methylguanine-DNA methyltransferase (MGMT) promoter. Fol
Autor:
Jan-Michael Werner, Lena Wolf, Caroline Tscherpel, Elena K. Bauer, Michael Wollring, Garry Ceccon, Martina Deckert, Anna Brunn, Roberto Pappesch, Roland Goldbrunner, Gereon R. Fink, Norbert Galldiks
Publikováno v:
Journal of neuro-oncology 159(2), 309-317 (2022). doi:10.1007/s11060-022-04066-9
Background The phase 2 REGOMA trial suggested an encouraging overall survival benefit in glioblastoma patients at first relapse treated with the multikinase inhibitor regorafenib. Here, we evaluated the efficacy and side effects of regorafenib in a r
Autor:
Jurij, Rosen, Garry, Ceccon, Elena K, Bauer, Jan-Michael, Werner, Caroline, Tscherpel, Veronika, Dunkl, Marion, Rapp, Michael, Sabel, Ulrich, Herrlinger, Alexander, Heinzel, Niklas, Schäfer, Maximilian, Ruge, Roland, Goldbrunner, Gabriele, Stoffels, Christoph, Kabbasch, Gereon R, Fink, Karl-Josef, Langen, Norbert, Galldiks
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 63(11)
In light of increasing health-care costs, higher medical expenses should be justified socioeconomically. Therefore, we calculated the effectiveness and cost effectiveness of PET using the radiolabeled amino acid